Stefanos Kikionis

Dr. Stefanos Kikionis

Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2017 in Bioengineering
Verified
Journal Article
Open access
PDF file
KMKotronia Margarita
Kotronia Margarita
EKEleni Kavetsou
Eleni Kavetsou
SLSofia Loupassaki
Sofia Loupassaki
SKStefanos Kikionis
Stefanos Kikionis
Stamatina VouyioukaStamatina Vouyiouka
Stamatina Vouyiouka
Anastasia DetsiAnastasia Detsi
Anastasia Detsi
The aim of the present work was to study the encapsulation of Origanum onites L. essential oil (oregano EO) in β-cyclodextrin (β-CD) inclusion complexes (ICs), using the co-precipitation method. The formed β-CD–oregano EO ICs were characterized by diverse methods, such as Dynamic Light Scattering (DLS), FT-IR spectroscopy, Differential Scanning Calorimetry (DSC), Thermogravimetric Analysis (TGA), Nuclear Magnetic Resonance (NMR) spectroscopy and Scanning Electron Microscopy (SEM). UV-Vis spectroscopy was used for the determination of the inclusion efficacy and the study of the encapsulated oregano EO release profile. The interactions between host (β-CD) and guest (oregano EO) in the formed ICs were proven by the FT-IR, DSC, TG and NMR analyses. The ICs, which derived from different batches, presented nanoscale size (531.8 ± 7.7 nm and 450.3 ± 11.5 nm, respectively), good size dispersion (0.308 ± 0.062 and 0.484 ± 0.029, respectively) and satisfactory stability in suspension (ζ-potential = −21.5 ± 1.2 mV and −30.7 ± 1.8 mV). Inclusion efficiency reached up to 26%, whereas the oregano EO release from the ICs followed a continuous delivery profile for up to 11 days, based on in vitro experiments. The formed ICs can find diverse applications, such as in the preparation of films for active packaging of food products, in personal care products for the improvement of their properties (e.g., antioxidant, antimicrobial, etc.), as well as in insect repellent products.

21 March 2015 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
SKStefanos Kikionis
Stefanos Kikionis
Efstathia IoannouEfstathia Ioannou
Efstathia Ioannou
GTGeorgios Toskas
Georgios Toskas
Vassilios RoussisVassilios Roussis
Vassilios Roussis

5 May 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
KIKonstantina Iliou
Konstantina Iliou
SKStefanos Kikionis
Stefanos Kikionis
Efstathia IoannouEfstathia Ioannou
Efstathia Ioannou
Vassilios RoussisVassilios Roussis
Vassilios Roussis
Marine biopolymers, abundantly present in seaweeds and marine animals, feature diverse structures and functionalities, and possess a wide range of beneficial biological activities. Characterized by high biocompatibility and biodegradability, as well as unique physicochemical properties, marine biopolymers are attracting a constantly increasing interest for the development of advanced systems for applications in the biomedical field. The development of electrospinning offers an innovative technological platform for the production of nonwoven nanofibrous scaffolds with increased surface area, high encapsulation efficacy, intrinsic interconnectivity, and structural analogy to the natural extracellular matrix. Marine biopolymer-based electrospun nanofibrous scaffolds with multifunctional characteristics and tunable mechanical properties now attract significant attention for biomedical applications, such as tissue engineering, drug delivery, and wound healing. The present review, covering the literature up to the end of 2021, highlights the advancements in the development of marine biopolymer-based electrospun nanofibers for their utilization as cell proliferation scaffolds, bioadhesives, release modifiers, and wound dressings.

9 April 2020 in Materials
Verified
Journal Article
Open access
PDF file
Leto-Aikaterini TzivelekaLeto-Aikaterini Tziveleka
Leto-Aikaterini Tziveleka
Andreas SapalidisAndreas Sapalidis
Andreas Sapalidis
SKStefanos Kikionis
Stefanos Kikionis
EAEleni Aggelidou
Eleni Aggelidou
EDEfterpi Demiri
Efterpi Demiri
Vassilios RoussisVassilios Roussis
Vassilios Roussis
Ulvan, a bioactive natural sulfated polysaccharide, and gelatin, a collagen-derived biopolymer, have attracted interest for the preparation of biomaterials for different biomedical applications, due to their demonstrated compatibility for cell attachment and proliferation. Both ulvan and gelatin have exhibited osteoinductive potential, either alone or in combination with other materials. In the current work, a series of novel hybrid scaffolds based on crosslinked ulvan and gelatin was designed, prepared and characterized. Their mechanical performance, thermal stability, porosity, water-uptake and in vitro degradation ability were assessed, while their morphology was analyzed through scanning electron microscopy. The prepared hybrid ulvan/gelatin scaffolds were characterized by a highly porous and interconnected structure. Human adipose-derived mesenchymal stem cells (hADMSCs) were seeded in selected ulvan/gelatin hybrid scaffolds and their adhesion, survival, proliferation, and osteogenic differentiation efficiency was evaluated. Overall, it was found that the prepared hybrid sponge-like scaffolds could efficiently support mesenchymal stem cells’ adhesion and proliferation, suggesting that such scaffolds could have potential uses in bone tissue engineering.

1 September 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
PPParaskevi Papakyriakopoulou
Paraskevi Papakyriakopoulou
KMKonstantina Manta
Konstantina Manta
CKChristina Kostantini
Christina Kostantini
SKStefanos Kikionis
Stefanos Kikionis
SBSabrina Banella
Sabrina Banella
GCGaia Colombo
Gaia Colombo

17 September 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MVMarilena Vlachou
Marilena Vlachou
SKStefanos Kikionis
Stefanos Kikionis
Angeliki SiamidiAngeliki Siamidi
Angeliki Siamidi
SKSotiria Kyriakou
Sotiria Kyriakou
Andrew TSOTINISAndrew TSOTINIS
Andrew TSOTINIS
Vassilios RoussisVassilios Roussis
Vassilios Roussis
Furosemide, a chloride channel blocker ordinarily used as a high-ceiling or loop diuretic, is practically insoluble in water and dilute acids. Due to its acidic nature, furosemide is mostly absorbed in the stomach and in the upper small intestine. Efforts have focused on the development of sustained release systems of furosemide in order to improve the effectiveness of the drug, which exhibits poor aqueous solubility and poor permeability. Recently, electrospun nanofibrous drug delivery systems have emerged as promising alternative solid-dosage forms due to their advantages of high porosity, high surface to volume ratio, and high drug-loading efficacy. Herein, a number of nanofibrous mats composed of different types of Eudragit® polymers in various concentrations and combinations loaded with furosemide were designed, successfully electrospun, and characterized using SEM, FTIR, DSC, and TGA analyses. The nanofibrous nonwovens were formulated in nanofiber tablets and the release profile of furosemide from them was evaluated at pH 1.2 and 6.8 and compared to that of physical mixture matrix tablets of analogous composition as well as to that of a commercial formulation. It was found that the release of furosemide was compatible with the gastroretentive and slower intestinal release requirements with a well-defined absorption window, while some nanofiber formulations could act as furosemide carriers in emergency situations where a relatively fast onset of its action is required, as in the case of critically ill post-traumatic patients.